A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging. . . . → Read More: Biotech Licenses mRNA Technology for Aging
|
|||||
|
       
  |
Results of a clinical trial show stem cells from umbilical cord linings help patients with severe respiratory disease recover and survive from Covid-19 infections. . . . → Read More: Stem Cells Help Severe Covid-19 Cases Recover  One comment - (Comments are closed)  New products  biomedical, clinical trials, Covid-19, life sciences, pharmaceuticals, stem cells, university 
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, entrepreneurs, FDA, genomics, life sciences, manufacturing, pharmaceuticals, stem cells, university 
Results from an early clinical trial of stem cells to treat amyotrophic lateral sclerosis, or ALS, shows the therapy is safe and slows progression of the disease. . . . → Read More: ALS Stem Cell Treatments Found Safe, Slow Progression Comments are closed New products biomedical, biotechnology, clinical trials, Israel, life sciences, pharmaceuticals, stem cells, university 
Results of a clinical trial show a treatment for multiple sclerosis from patients’ stem cells slows progression of the disease and improves walking ability. . . . → Read More: Trial Shows Stem Cell Therapy Slows M.S. Progression One comment - (Comments are closed) New products biomedical, biotechnology, clinical trials, entrepreneurs, Israel, licensing, life sciences, pharmaceuticals, stem cells 
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies Comments are closed Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, stem cells, university, venture capital 
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal Comments are closed Intellectual property, Joint ventures/collaborations Australia, biomedical, biotechnology, clinical trials, Covid-19, equity, Europe, FDA, investment, licensing, life sciences, manufacturing, pharmaceuticals, stem cells 
Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo. . . . → Read More: ALS Stem Cell Therapy Fails to Meet Trial Objective Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals, stem cells 
Interim clinical trial results show an experimental treatment derived from gene-edited stem cells relieves symptoms in patients with severe inherited blood diseases. . . . → Read More: Crispr Therapy Shown to Help Blood Disorder Patients Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, Europe, genomics, life sciences, pharmaceuticals, stem cells 
The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infections, and other processes. . . . → Read More: FDA to Use Lung Chip Model for Covid-19 Testing 2 comments - (Comments are closed) Joint ventures/collaborations, Regulations biomedical, Covid-19, engineering, FDA, life sciences, medical device, pharmaceuticals, stem cells |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||